{"id":"https://openalex.org/W4282969769","doi":"https://doi.org/10.1016/j.bonr.2022.101449","title":"Differences between the effects of anti-catabolic zoledronate and anabolic teriparatide treatments on bone in adult ovariectomized rats","display_name":"Differences between the effects of anti-catabolic zoledronate and anabolic teriparatide treatments on bone in adult ovariectomized rats","publication_year":2022,"publication_date":"2022-05-01","ids":{"openalex":"https://openalex.org/W4282969769","doi":"https://doi.org/10.1016/j.bonr.2022.101449"},"language":"en","primary_location":{"id":"doi:10.1016/j.bonr.2022.101449","doi":"https://doi.org/10.1016/j.bonr.2022.101449","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bonr.2022.101449","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2352187222002844/pdf","source":{"id":"https://openalex.org/S2764541639","display_name":"Bone Reports","issn_l":"2352-1872","issn":["2352-1872"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bone Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2352187222002844/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080592958","display_name":"Jukka P. Morko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Jukka Morko","raw_affiliation_strings":["Pharmatest Services, Skeletal disease models, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmatest Services, Skeletal disease models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027087048","display_name":"Jukka V\u00e4\u00e4r\u00e4niemi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jukka V\u00e4\u00e4r\u00e4niemi","raw_affiliation_strings":["Pharmatest Services, Skeletal disease models, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmatest Services, Skeletal disease models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112382265","display_name":"Katja M. Fagerlund","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Katja M. Fagerlund","raw_affiliation_strings":["Pharmatest Services, In vitro models, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmatest Services, In vitro models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034825484","display_name":"Mari I. Suominen","orcid":"https://orcid.org/0000-0002-8760-6595","observed_orcids":["https://orcid.org/0000-0002-8760-6595"]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Mari I. Suominen","raw_affiliation_strings":["Pharmatest Services, Cancer models, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmatest Services, Cancer models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061315354","display_name":"Jukka P. Rissanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124546","display_name":"Pharmatest (Finland)","ror":"https://ror.org/02fkt1r75","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210124546"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jukka P. Rissanen","raw_affiliation_strings":["Pharmatest Services, Cancer models, Turku, Finland","Pharmatest Services, In vitro models, Turku, Finland","Pharmatest Services, Skeletal disease models, Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmatest Services, Cancer models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]},{"raw_affiliation_string":"Pharmatest Services, In vitro models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]},{"raw_affiliation_string":"Pharmatest Services, Skeletal disease models, Turku, Finland","institution_ids":["https://openalex.org/I4210124546"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5080592958"],"corresponding_institution_ids":["https://openalex.org/I4210124546"],"apc_list":{"value":2060,"currency":"USD","value_usd":2060},"apc_paid":{"value":2060,"currency":"USD","value_usd":2060},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10086005,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"101449","last_page":"101449"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.01810000091791153,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11219","display_name":"Bone Metabolism and Diseases","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":0.9319999814033508},{"id":"https://openalex.org/keywords/teriparatide","display_name":"teriparatide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anabolic-therapy","display_name":"anabolic therapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/bone-loss","display_name":"bone loss","score":0.6230000257492065},{"id":"https://openalex.org/keywords/ovariectomy","display_name":"ovariectomy","score":0.9200000166893005},{"id":"https://openalex.org/keywords/postmenopausal-osteoporosis","display_name":"postmenopausal osteoporosis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/bone-formation","display_name":"bone formation","score":0.527999997138977},{"id":"https://openalex.org/keywords/bone-resorption","display_name":"bone resorption","score":0.7440000176429749},{"id":"https://openalex.org/keywords/rat-model","display_name":"rat model","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C8264082","wikidata":"https://www.wikidata.org/wiki/Q7113259","display_name":"Ovariectomized rat","level":3,"score":0.9427436590194702},{"id":"https://openalex.org/C1008401","wikidata":"https://www.wikidata.org/wiki/Q184681","display_name":"Anabolism","level":2,"score":0.8518933057785034},{"id":"https://openalex.org/C2777308945","wikidata":"https://www.wikidata.org/wiki/Q411781","display_name":"Teriparatide","level":4,"score":0.8158451318740845},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6148168444633484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6000954508781433},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.5566328167915344},{"id":"https://openalex.org/C96942376","wikidata":"https://www.wikidata.org/wiki/Q21130714","display_name":"Catabolism","level":3,"score":0.502661943435669},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4136929512023926},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34984463453292847},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.21831080317497253},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.20434126257896423},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.07533681392669678}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.bonr.2022.101449","doi":"https://doi.org/10.1016/j.bonr.2022.101449","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bonr.2022.101449","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2352187222002844/pdf","source":{"id":"https://openalex.org/S2764541639","display_name":"Bone Reports","issn_l":"2352-1872","issn":["2352-1872"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bone Reports","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.bonr.2022.101449","doi":"https://doi.org/10.1016/j.bonr.2022.101449","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.bonr.2022.101449","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2352187222002844/pdf","source":{"id":"https://openalex.org/S2764541639","display_name":"Bone Reports","issn_l":"2352-1872","issn":["2352-1872"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bone Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4282969769.pdf","grobid_xml":"https://content.openalex.org/works/W4282969769.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313339932","https://openalex.org/W4311303405","https://openalex.org/W3210938536","https://openalex.org/W2399509978","https://openalex.org/W4282973934","https://openalex.org/W4225386970","https://openalex.org/W2980179877","https://openalex.org/W4393638148","https://openalex.org/W4320001468","https://openalex.org/W2903200191"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2022-06-17T00:00:00"}